These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 25572918)
1. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat. Khan S; Jena G; Tikoo K; Kumar V Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918 [TBL] [Abstract][Full Text] [Related]
2. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat. Khan S; Jena G; Tikoo K Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297 [TBL] [Abstract][Full Text] [Related]
3. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway. Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993 [TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats. Khan S; Jena G Food Chem Toxicol; 2014 Nov; 73():127-39. PubMed ID: 25158305 [TBL] [Abstract][Full Text] [Related]
5. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. Li Y; Yuan Z; Liu B; Sailhamer EA; Shults C; Velmahos GC; Demoya M; Alam HB J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049 [TBL] [Abstract][Full Text] [Related]
6. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3. Chen S; Ye J; Chen X; Shi J; Wu W; Lin W; Lin W; Li Y; Fu H; Li S J Neuroinflammation; 2018 May; 15(1):150. PubMed ID: 29776446 [TBL] [Abstract][Full Text] [Related]
7. Sodium valproate attenuates the iE-DAP induced inflammatory response by inhibiting the NOD1-NF-κB pathway and histone modifications in bovine mammary epithelial cells. Gao Q; Wang Y; Ma N; Dai H; Roy AC; Chang G; Shi X; Shen X Int Immunopharmacol; 2020 Jun; 83():106392. PubMed ID: 32182568 [TBL] [Abstract][Full Text] [Related]
8. Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis. Sun XY; Qin HJ; Zhang Z; Xu Y; Yang XC; Zhao DM; Li XN; Sun LK Mol Med Rep; 2016 Jan; 13(1):661-8. PubMed ID: 26647757 [TBL] [Abstract][Full Text] [Related]
9. Neuregulin 4 Attenuates Podocyte Injury and Proteinuria in Part by Activating AMPK/mTOR-Mediated Autophagy in Mice. Deng J; Yang Q; Zhu W; Zhang Y; Lin M; She J; Li J; Xiao Y; Xiao J; Xu X; He H; Zhu B; Ding Y J Cell Biochem; 2024 Oct; 125(10):e30634. PubMed ID: 39091188 [TBL] [Abstract][Full Text] [Related]
10. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. Zhu L; Han J; Yuan R; Xue L; Pang W Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956 [TBL] [Abstract][Full Text] [Related]
11. Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy. Liu Y; Liu W; Zhang Z; Hu Y; Zhang X; Sun Y; Lei Q; Sun D; Liu T; Fan Y; Li H; Ding W; Fang J Ren Fail; 2021 Dec; 43(1):128-140. PubMed ID: 33427556 [TBL] [Abstract][Full Text] [Related]
12. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469 [TBL] [Abstract][Full Text] [Related]
13. Valproic Acid Improves Glucose Homeostasis by Increasing Beta-Cell Proliferation, Function, and Reducing its Apoptosis through HDAC Inhibition in Juvenile Diabetic Rat. Khan S; Jena G J Biochem Mol Toxicol; 2016 Sep; 30(9):438-46. PubMed ID: 27079868 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296 [TBL] [Abstract][Full Text] [Related]
15. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993 [TBL] [Abstract][Full Text] [Related]
16. ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte. Yuan S; Liang X; He W; Liang M; Jin J; He Q Ren Fail; 2021 Dec; 43(1):968-979. PubMed ID: 34157937 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats. Chen J; Chen Y; Luo Y; Gui D; Huang J; He D Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932 [TBL] [Abstract][Full Text] [Related]
18. Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway. Han J; Pang X; Zhang Y; Peng Z; Shi X; Xing Y Drug Des Devel Ther; 2020; 14():3223-3234. PubMed ID: 32848363 [TBL] [Abstract][Full Text] [Related]
19. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]